Skip to main content
    M

    Medical Properties Trust, Inc. (MPT)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE

    $1.58
    +0.08 (+5.33%)

    Market Cap: $983.46M

    Last updated: Nov 17, 2026 at 4:37 PM ET

    Medical Properties Trust, Inc. (MPT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Medical Properties Trust (MPT) has a market cap of $983.46M and a P/FFO of 3.4x on its 2026 FFO estimate. Its net debt of $8.66B equals 880.66% of its market cap. Its dividend yield is 22.78%.

    Total Valuation

    Enterprise value is 880.66% above the market cap, as debt exceeds cash.

    Market Cap$983.46M
    Enterprise Value$9.64B
    Latest price (Nov 17, 2026)$1.58

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 10, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Last Ex-Dividend DateSep 10, 2026
    Last Payment DateOct 8, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.13% in the quarter ended Sep 30, 2026 and shrank 0.26% a year over 2 years.

    Shares Outstanding597.16M
    Shares Change (YoY)-0.62%
    Shares Change (QoQ)-0.13%
    Share Count Growth (2Y CAGR)-0.26%

    Valuation Ratios

    P/FFO is 3.4x on the 2026 FFO estimate of $0.46 a share. Its year-end P/S ranged from 2.4x to 10.6x from 2016 to 2025.

    P/FFO (2026 estimate)3.4x
    P/E Ratio4.2x
    Forward P/E17.8x
    P/S Ratio0.9x
    Forward P/S1.0x
    P/B Ratio0.2x
    P/OCF Ratio3.9x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 7.1x EBITDA.

    EV / Earnings38.7x
    EV / Sales9.3x
    EV / EBITDA7.1x
    EV / EBIT9.0x

    Price Statistics

    The stock is down 66.28% over 52 weeks and trades 45.14% below its 50-day average.

    Beta (1Y)0.87
    52-Week Change-66.28%
    1-Month Change-44.56%
    3-Month Change-61.09%
    6-Month Change-66.98%
    5-Year Change-89.45%
    10-Year Change-83.86%
    Total Return (1Y)-58.60%
    Total Return (3Y CAGR)-24.34%
    Total Return (5Y CAGR)-35.69%
    Return vs SPY (1Y)-78.83%
    Max Drawdown (1Y)-74.13%
    Max Drawdown (3Y)-74.13%
    Sharpe Ratio (1Y)-2.62
    Correlation with SPY (1Y)0.28
    50-Day Average$2.88
    200-Day Average$4.25
    52-Week Range$1.48 to $6.09
    RSI (14 Days)17.8
    Average Volume (20 Days)23.84M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.49x current liabilities, and total debt is 2.00x shareholder equity.

    Current Ratio1.49x
    Quick Ratio1.49x
    Debt / Equity2.00x
    Debt / EBITDA6.85x
    Debt / FCF339.22x
    Interest Coverage1.93x

    Returns and Efficiency

    Return on invested capital is 7.70% over the last 12 months, against a 5-year average of -0.36%.

    Return on Equity (ROE)5.39%
    Return on Assets (ROA)1.73%
    Return on Invested Capital (ROIC)7.70%
    Return on Capital Employed (ROCE)7.65%
    ROE (5Y Average)-8.98%
    ROA (5Y Average)-2.79%
    ROIC (5Y Average)-0.36%
    Asset Turnover0.07x
    Receivables Turnover2.14x

    Scores

    MPT has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    FFO per share was $0.52 for 2025, the latest reported year. Revenue of $1.03B over the last 12 months is up 10.13% from the 12 months before.

    FFO Per Share (2025)$0.52
    Revenue$1.03B
    Revenue Growth (YoY)+10.13%
    Gross Profit$850.86M
    Operating Income$568.66M
    Pretax Income$246.28M
    Net Income$249.13M
    EBITDA$1.35B
    EBIT$1.07B
    Reported EPS (TTM)$0.38

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 32.11% of the $14.39B in total assets.

    Cash and Equivalents$599.28M
    Total Debt$9.26B
    Net Debt$8.66B
    Net Debt Per Share$14.50
    Working Capital$202.79M
    Shareholder Equity$4.62B
    Book Value Per Share$7.74
    Total Assets$14.39B
    Total Liabilities$9.77B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $222.09M of capital spending, operating cash flow left $27.30M of free cash flow.

    Operating Cash Flow$249.39M
    Capital Expenditures$222.09M
    Free Cash Flow$27.30M
    FCF Per Share$0.05
    Depreciation and Amortization$298.00M
    Dividends Paid$212.21M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 55.11%, against a 5-year average of 47.20%.

    Gross Margin82.46%
    Operating Margin55.11%
    Pretax Margin23.87%
    Net Margin24.14%
    EBITDA Margin130.99%
    EBIT Margin103.58%
    FCF Margin2.65%
    Gross Margin (5Y Average)96.65%
    Operating Margin (5Y Average)47.20%
    Net Margin (5Y Average)-46.69%

    Growth

    FFO per share fell 33.27% a year over 3 years, and revenue 14.27% a year.

    FFO Per Share Growth (3Y CAGR)-33.27%
    Revenue Growth (3Y CAGR)-14.27%
    Revenue Growth (5Y CAGR)-4.89%
    Operating Income Growth (3Y CAGR)-18.68%
    Book Value Per Share Growth (2Y CAGR)-22.43%
    Tangible Book Per Share Growth (2Y CAGR)-30.15%

    Revenue and profit by year

    Dividends and Yields

    MPT pays out 69.23% of 2025 FFO as dividends.

    Dividend Per Share (Annual)$0.36
    Dividend Yield22.78%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-34.23%
    Dividend Growth (5Y CAGR)-21.11%
    Payout Ratio (2025 FFO)69.23%
    FFO Yield (2025)32.91%
    Shareholder Yield22.49%

    Full dividend history

    Peer Position

    Against 12 similar companies, MPT has the lowest P/FFO and the 12th highest P/S.

    P/FFO3.4x vs 11.2x median
    P/S Ratio0.9x vs 5.2x median
    ROIC7.70% vs 1.87% median
    Revenue Growth (Trailing 4 Quarters, YoY)+10.13% vs +15.81% median
    Dividend Yield22.78% vs 4.59% median

    Competitors compared

    Analyst Forecast

    FFO per share estimates imply 10.13% decline a year over the next 2 years. Consensus estimates put revenue growth at 3.89% a year over the next 2 fiscal years.

    FFO Per Share Growth Forecast (2Y CAGR)-10.13%
    Revenue Growth Forecast (2Y CAGR)+3.89%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MPT

    What is MPT's market cap?

    Medical Properties Trust has a market cap of $983.46M. Its enterprise value, which adds debt and subtracts cash, is $9.64B.

    What is MPT's P/E ratio?

    Medical Properties Trust has a P/FFO of 3.4x on its 2026 FFO estimate. Its trailing P/E ratio is 4.2x and its forward P/E is 17.8x.

    How many shares of MPT are outstanding?

    Medical Properties Trust has 597.16M shares outstanding. The count is down 0.62% from a year earlier.

    Does MPT pay a dividend?

    Yes. Medical Properties Trust pays $0.36 a share a year, a dividend yield of 22.78%.

    How much debt does MPT have?

    Medical Properties Trust has $9.26B of total debt and $599.28M of cash and equivalents, a net debt position of $8.66B.